ABSTRACT CT014Credit: The University of Texas MD Anderson Cancer Center ABSTRACT CT014 SAN DIEGO – The first-in-class PARP1-selective inhibitor saruparib...

ABSTRACT CT013Credit: The University of Texas MD Anderson Cancer Center ABSTRACT CT013 SAN DIEGO ― Combining the KRAS G12C inhibitor...

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®)—a nonprofit devoted to patient care, research, and education—is announcing the...

ABSTRACTS: CT002, CT003Credit: The University of Texas MD Anderson Cancer Center ABSTRACTS: CT002, CT003 SAN DIEGO ― Researchers from The...

New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer...

New research could pave the way to develop cancer drugs targeting an enzyme that inhibits ferroptosis, a type of cell...

Scientists at St. Jude Children’s Research Hospital are preparing to demonstrate their expertise and foster collaborations at the American Association...

Boston - Numerous studies conducted by researchers at Dana-Farber Cancer Institute show promising results for patients with endometrial, lung, breast, prostate,...

Two researchers from The University of Texas MD Anderson Cancer Center will be honored with Scientific Achievement Awards at the American Association for...

MIAMI, FLORIDA (EMBARGOED UNTIL APRIL 4, 2024, at 6:30 pm EDT) – Annual prostate cancer cases worldwide are projected to...